Doxycycline revisited
- PMID: 9224219
Doxycycline revisited
Abstract
Although several new antibiotics have recently become available, in several clinical instances conventional antibiotics may be equally efficacious at a considerably lower cost. In today's era of cost containment, it is particularly relevant to revisit older, inexpensive antibiotics to reexplore their role in the face of the emergence of resistant microorganisms and competition from newer agents. Doxycycline is one such antibiotic. It is an inexpensive, broad-spectrum antimicrobial agent that remains the drug of first choice for several infections. In addition, it can be used for a variety of other indications. Adverse effects are infrequent and relatively minor. While interactions occur with several medications, none of these interactions has significant adverse consequences.
Comment in
-
Rash decisions.Arch Intern Med. 1998 Jan 26;158(2):191. doi: 10.1001/archinte.158.2.191. Arch Intern Med. 1998. PMID: 9448558 No abstract available.
-
Doxycycline revisited: an old medicine for emerging diseases.Arch Intern Med. 1998 Jan 26;158(2):192-3. doi: 10.1001/archinte.158.2.192-a. Arch Intern Med. 1998. PMID: 9448562 No abstract available.
-
Doxycycline: new ways to use an old antibiotic.Arch Intern Med. 1998 Apr 27;158(8):928-9. doi: 10.1001/archinte.158.8.928-b. Arch Intern Med. 1998. PMID: 9570183 No abstract available.
-
Revisiting doxycycline.Arch Intern Med. 1998 Jul 13;158(13):1469-70. doi: 10.1001/archinte.158.13.1469-a. Arch Intern Med. 1998. PMID: 9665360 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
